DH Stock Analysis: Buy, Sell, or Hold?
DH - Definitive Healthcare Corp. Class A Common Stock
$0.81
-0.09 (-9.79%)
▼
5d:
-2.29%
30d:
-9.49%
90d:
-24.12%
BUY
HIGH Confidence
Analysis Updated: Jul 8, 2026 12:00 AM ET
Earnings: Aug 06, 2026
28d
Get Alerted When DH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: DH trading at deep discount. Market pricing in -9.1% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: DH trading at deep discount. Market pricing in -9.1% annual earnings decline, creating value opportunity for patient investors.
In-depth Analysis How we analyze
Valuation Analysis: DH is currently trading at $0.81, which is considered fair relative to its 30-day fair value range of $0.74 to $0.90. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.0) compared to its historical average (6.6). Remarkably, the market is currently pricing in an annual earnings decline of 9.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DH is in a strong downtrend. The price is currently testing key support at $0.83. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.8% recently.
Market Sentiment: DH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.20 (+144.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DH is in a strong downtrend. The price is currently testing key support at $0.83. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.8% recently.
Market Sentiment: DH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.20 (+144.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.74 -
$0.90
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.8%)
- BULLISH: Trading 144.4% below Wall St target ($2.20)
Trading Range Analysis
30-Day Trading Range
$0.74 -
$0.90
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.83
Resistance Level
$1.01
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.97
Wall Street Target
$2.20
(+144.4%)
Revenue Growth (YoY)
-5.5%
Profit Margin
-71.5%
Valuation Discount vs History
-9.1% cheaper
PE vs Historical
5.0 vs 6.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.1%
(market-implied from PE analysis)
1-Year Target
$0.82
(-9%)
2-Year Target
$0.74
(-17%)
3-Year Target
$0.68
(-25%)
3-Yr Target (if PE normalizes)
(PE: 5→7)
$0.90
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -1.7%)
$3.74
(+316%)
Base:
(SPY PE: 5.0, Growth: -1.7%)
$0.85
(-5%)
Bear:
(PE: 4.2, Growth: -1.7%)
$0.73
(-19%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.0 to 6.6
Stabilization Target:
$1.20
(+32.8%)
PE Expansion Potential:
+32.8%
Share & Embed Analysis
Last updated: July 08, 2026 4:47 PM ET
Data refreshes hourly during market hours. Next update: 5:47 PM
Data refreshes hourly during market hours. Next update: 5:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 57 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 63 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 61 BUY |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$34 | 60 HOLD |
